QT
ARQT icon

Quantamental Technologies’s Arcutis Biotherapeutics ARQT Stock Holding History

Quantamental Technologies’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,304
Closed -$98.2K – 313
2023
Q2 		$98.2K Buy
+10,304
New +$114K 0.04% 432

Other funds holding ARQT

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Quantamental Technologies's ARQT Position: Q3 2023 in Review

Quantamental Technologies sold out of Arcutis Biotherapeutics (ARQT) in Q3 2023, closing a stake of 10,304 shares — an estimated $98.2K sold.

Quantamental Technologies first reported a position in ARQT in Q2 2023 and held it in 1 quarter. The position peaked at $98.2K in Q2 2023. 134 funds tracked by Wall St. Rank hold ARQT as of Q3 2023.

  • Quantamental Technologies reported no remaining Arcutis Biotherapeutics position as of Q3 2023 after selling out during the quarter.
  • Quantamental Technologies sold 10,304 Arcutis Biotherapeutics shares in Q3 2023, an estimated $98.2K.
  • Quantamental Technologies first reported a position in Arcutis Biotherapeutics in Q2 2023 and held it in 1 quarter.
  • Quantamental Technologies's Arcutis Biotherapeutics position peaked at $98.2K in Q2 2023.
  • 134 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.